Publication | Open Access

Drug delivery of memantine with carbon dots for Alzheimer’s disease: blood–brain barrier penetration and inhibition of tau aggregation

NanomedicineNeurodegenerative DiseasesDrug TargetingAlzheimer's DiseaseEngineeringMedicineDrug Delivery SystemsNano-drug DeliveryNeuroprotectionBiomedical EngineeringCarbon DotsPharmacologyTau Aggregation